Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes
Medicina Clínica · 2025-12 · 165 (6) · 107179
DOI: 10.1016/j.medcli.2025.107179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina Clínica, 2025-12. Verfasst von Jorge Gabriel Ruiz-Sánchez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Instituto de Investigación Sanitaria Fundación Jiménez-Díaz (…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Blood Pressure, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Instituto de Investigación Sanitaria Fundación Jiménez Díaz.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Instituto de Investigación Sanitaria Fundación Jiménez-Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), Hospital Universitario…
- Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Endocrinology Department, Hospital Universitario General de Villalba, Madrid, Spain.
- Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
- Endocrinology Department, Hospital Universitario Infanta Elena, Madrid, Spain.
- Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Endocrinology Department, Hospital Universitario Infanta Elena, Madrid, Spain.
Förderung
- Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Zitieren
APA
Ruiz-Sánchez, J. G., Sierra Poyatos, R. M., Luiza Luca, B., Sánchez-Lechuga, B., Modroño Móstoles, N., Montoya Álvarez, T., Meneses, D., Sánchez-Lopez, R., Casado Cases, C., Pérez de Arenaza Pozo, V., Vázquez, C., & Cárdenas-Salas, J. J. (2025). Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes. Medicina Clínica, 165(6), 107179. https://doi.org/10.1016/j.medcli.2025.107179
Vancouver
Ruiz-Sánchez JG, Sierra Poyatos RM, Luiza Luca B, Sánchez-Lechuga B, Modroño Móstoles N, Montoya Álvarez T, et al. Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes. Medicina Clínica. 2025;165(6):107179. doi:10.1016/j.medcli.2025.107179
BibTeX
@article{RuizSnchez2025,
author = {Ruiz-Sánchez, Jorge Gabriel and Sierra Poyatos, Roberto Miguel and Luiza Luca, Bogdana and Sánchez-Lechuga, Begoña and Modroño Móstoles, Naiara and Montoya Álvarez, Teresa and Meneses, Diego and Sánchez-Lopez, Raquel and Casado Cases, Carlos and Pérez de Arenaza Pozo, Víctor and Vázquez, Clotilde and Cárdenas-Salas, Jersy Jair},
title = {Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes},
journal = {Medicina Clínica},
year = {2025},
volume = {165},
number = {6},
pages = {107179},
doi = {10.1016/j.medcli.2025.107179}
}
EUVIMED